Related Experiment Video
Updated: Jan 26, 2026

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
Putative loss of CD83 immunosuppressive activity in long-standing complication-free juvenile diabetic patients during
Ulana Juhas1, Monika Ryba-Stanisławowska2, Urszula Ławrynowicz2
1Department of Medical Immunology, Laboratory of Experimental Immunology, Medical University of Gdańsk, Dębinki 1, 80-211, Gdańsk, Poland. ulana.juhas@gumed.edu.pl.
Insights
Soluble CD83 (sCD83) levels are decreased in children with long-standing type 1 diabetes (DM1), correlating with poor metabolic control. This suggests sCD83 may be a therapeutic target for chronic diabetes complications.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- The soluble CD83 molecule (sCD83) has immunosuppressive functions and is a marker of dendritic cell differentiation.
- Monocyte-derived cells express CD83, and their differentiation process is crucial in immune regulation.
Purpose of the Study:
- To investigate sCD83 plasma concentration in children with type 1 diabetes (DM1).
- To assess the relationship between sCD83 levels and monocyte differentiation into CD83+ cells in DM1 patients.
- To explore potential therapeutic implications of sCD83 in DM1.
Main Methods:
- Analysis of sCD83 plasma concentration in 28 newly diagnosed (ND-DM1) and 30 long-standing (LS-DM1) patients.
- Evaluation of monocyte-derived CD83 (mCD83) expression and its regulation by TNF-α.
- Correlation analysis between sCD83 levels, HbA1c, TNF-α, and disease duration.
Main Results:
- Newly diagnosed DM1 patients showed high mCD83 expression, downregulated by TNF-α.
- Monocyte differentiation into CD83+ cells was impaired in LS-DM1 patients, with dysregulated mCD83 expression.
- LS-DM1 patients exhibited significantly decreased sCD83 plasma levels, negatively correlated with HbA1c.
Conclusions:
- Reduced sCD83 levels in LS-DM1 patients may indicate poor metabolic control.
- sCD83 dysregulation is linked to impaired monocyte differentiation in chronic DM1.
- Therapeutic administration of sCD83 could represent a novel treatment strategy for chronic diabetes.
Abstract:
The CD83 molecule is a known marker of dendritic cell differentiation process, and its soluble form (sCD83) exerts immunosuppressive functions. In our research, we examined whether the sCD83 plasma concentration is impaired in DM1 children and if the expected changes are in line with the disturbed process of monocyte's transformation into mCD83+ monocyte-derived cells. 28 newly diagnosed (ND-DM1) and 30 long-standing (LS-DM1) patients were enrolled into our study. We revealed that the examined cells show a high mCD83 expression level in ND-DM1, which was significantly downregulated by the TNF-α stimulation. The results were in line with those from healthy controls. We also observed that monocyte differentiation process into CD83+ cells was much defective in LS-DM1 children and the mCD83 expression level seems not to be controlled by TNF-α. Moreover, the sCD83 level was significantly decreased in plasma from LS-DM1 children and it was negatively related to HbA1c levels, while no correlations were observed between TNF-α plasma concentration or disease duration. Summarizing, our results suggest that reduced sCD83 levels may correspond with a poor metabolic control in LS-DM1 patients and therapeutic administration of this molecule may indicate a new therapy approach in the chronic phase of diabetes.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Standing Waves
Standing Electromagnetic Waves
Suppose a sheet of a perfect conductor is placed in the yz-plane, and a linearly polarized electromagnetic wave traveling in the...
Standing Waves in a Cavity

